Ex-Genentech staff indicted for JHL help

A federal grand jury has indicted three former Genentech employees and a former JHL Biotech staff member for stealing trade secrets from the originator and funnelling them to the Taiwanese biosimilars player to help it develop biosimilars of four of Genentech’s products: Rituxan (rituximab), Herceptin (trastuzumab), Pulmozyme (dornase alfa), and Avastin (bevacizumab).